Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Liabilities (2019 - 2025)

Korro Bio (KRRO) has disclosed Total Liabilities for 6 consecutive years, with $62.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities fell 2.18% year-over-year to $62.5 million, compared with a TTM value of $62.5 million through Sep 2025, down 2.18%, and an annual FY2024 reading of $65.8 million, up 27.19% over the prior year.
  • Total Liabilities was $62.5 million for Q3 2025 at Korro Bio, down from $65.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $65.8 million in Q4 2024 and bottomed at $8.9 million in Q4 2022.
  • Average Total Liabilities over 5 years is $50.5 million, with a median of $54.0 million recorded in 2022.
  • The sharpest move saw Total Liabilities tumbled 83.66% in 2022, then soared 564.91% in 2024.
  • Year by year, Total Liabilities stood at $54.5 million in 2021, then tumbled by 83.66% to $8.9 million in 2022, then skyrocketed by 480.83% to $51.8 million in 2023, then rose by 27.19% to $65.8 million in 2024, then dropped by 5.02% to $62.5 million in 2025.
  • Business Quant data shows Total Liabilities for KRRO at $62.5 million in Q3 2025, $65.3 million in Q2 2025, and $63.2 million in Q1 2025.